Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT05204888 · ClinicalTrials.gov registry record · NA
myAirvo 3 (High Flow Nasal Therapy; HFNT) for COPD Patients in the Home
A NA study of COPD, sponsored by Temple University.
- Recruiting
- Registry status
- NA
- Development phase
- 642
- Enrollment target
- 20
- Study locations
NCT05204888 is a NA study of COPD that is actively recruiting participants, run by Temple University. The registered enrollment target is 642 participants, below the 2,411-participant average among 85 other COPD trials with a reported enrollment target (73% lower). The trial reports 20 study locations across 11 states.
The verdict
NCT05204888, a NA study of COPD, is actively recruiting participants, sponsored by Temple University.
- RECRUITING
- Registry status
- NA
- Development phase
- 642 participants
- Enrollment target
- 20
- Study locations
Study Summary
Parallel-group, prospective, randomized, controlled phase III trial of home High flow Nasal Therapy (HFNT) via myAirvo 3 plus usual COPD medical care vs. usual COPD medical care, for at least 1 year and up to two years in 642 GOLD Grade D, Stages II-IV patients with moderate to very severe COPD at risk for moderate and severe exacerbations with a prior history of severe exacerbation requiring hospitalization within the past 6 weeks.
Conditions Studied
Interventions
- DEVICE Pulse oximeter
- DEVICE myAirvo3
Study Locations (20)
Florida
- University of Florida, Jacksonville - Jacksonville
- Alloy Clinical Research - Kissimmee
- Reliable Research, Inc. - Miami
- NewGen Health Group - Miami
- Destiny Research - Palmetto Bay
Ohio
- Cincinnati VA Medical Center - Cincinnati
- Cleveland Clinic Foundation - Cleveland
- Ohio State University Wexner Medical Center - Columbus
Pennsylvania
- St. Luke's University Health Network - Bethlehem
- Clinical Research Associates of Central Pennsylvania - DuBois
- Jeanes Hospital - Philadelphia
Massachusetts
- Tufts Medical Center - Boston
- Lahey Hospital and Medical Center - Burlington
Alabama
- UAB School of Medicine/Lung Health Center - Birmingham
Arizona
- Honor Health - Scottsdale
Illinois
- University of Chicago - Chicago
Iowa
- The Iowa Clinic - West Des Moines
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 642 participants |
| Start Date | 2022-02-02 |
| Est. Completion | 2027-03 |
| Phase | NA |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT05204888
The ClinicalTrials.gov registry entry for NCT05204888 describes a study currently listed as recruiting, categorized as NA. The registered enrollment target is 642 participants, a figure that helps gauge the scale of data the investigators plan to collect, below the 2,411-participant average among 85 other COPD trials with a reported enrollment target (73% lower). The listed sponsor is Temple University, which has 163 total studies on file at ClinicalTrials.gov.
The record links to 1 condition, with COPD appearing as the primary indexed condition, and to 2 interventions - of which Pulse oximeter is the first listed.
NCT05204888 reports 20 study locations spanning 11 distinct geographic areas - top geographies include Florida, Ohio, Pennsylvania.
Frequently Asked Questions
What is clinical trial NCT05204888 about?
NCT05204888 is a clinical study titled "myAirvo 3 (High Flow Nasal Therapy; HFNT) for COPD Patients in the Home". Parallel-group, prospective, randomized, controlled phase III trial of home High flow Nasal Therapy (HFNT) via myAirvo 3 plus usual COPD medical care vs. usual COPD medical care, for at least 1 year and up to two years in 642 GOLD Grade D, Stages II-IV patients with moderate to very severe COPD at r...
What is the current status of trial NCT05204888?
This trial is currently recruiting. It is a NA study. The enrollment target is 642 participants. The study started on 2022-02-02. Estimated completion is 2027-03.
What conditions does trial NCT05204888 study?
This clinical trial studies the following conditions: COPD.
What interventions are being tested in trial NCT05204888?
The interventions under investigation include: Pulse oximeter (DEVICE), myAirvo3 (DEVICE).
Who is sponsoring clinical trial NCT05204888?
This trial is sponsored by Temple University, which has 163 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT05204888 being conducted?
This trial has 20 study locations across Alabama, Arizona, Florida, Illinois, Iowa. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for COPD
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
-
Impact of Positive Airway Pressure Therapy on Clinical Outcomes in Older Veterans With Chronic Obstructive Pulmonary Disease and Comorbid Obstructive Sleep Apnea (Overlap Syndrome)
RECRUITING · NA
-
Evaluating the Safety and Efficacy of dNerva Lung Denervation System in Patients With COPD
RECRUITING · NA
-
Home Hospital for Suddenly Ill Adults
RECRUITING · NA
-
The Reducing REVISITS Study: A Cluster RCT
RECRUITING · NA
-
The Effect of a Technology-Mediated Integrated Walking and Tai Chi Intervention on Physical Function in Veterans With COPD and Chronic Musculoskeletal Pain
RECRUITING · NA
-
Closed Loop Oxygen Control in Chronic Obstructive Pulmonary Disease (COPD) Patients Treated With Nasal High Flow in the Hospital
RECRUITING · NA
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.